Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$0 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-10.7 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0
Industry P/E
44.78
EV/EBITDA
0
Div. Yield
0 %
Debt to Equity
0.2
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
6,388,876
CFO
$-116.57 Mln
EBITDA
$-131.30 Mln
Net Profit
$-141.53 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Motus GI Holdings (MOTS)
| -- | -- | -- | -- | -98.1 | -95.1 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|
|
Motus GI Holdings (MOTS)
| -89.9 | -91.0 | -50.7 | -58.6 | -26.4 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Motus GI Holdings (MOTS)
|
0.0 | 0.0 | 0.3 | -10.6 | -2,344.0 | -- | -- | 0.0 |
| 7.9 | 5,388.2 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 278.3 | 7,510.1 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10 | 1.0 | |
| 36.8 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 112.8 | 6,549.6 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.0 | |
| 76.1 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.6 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 330.4 | 12,964.3 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.9 | 9.0 | |
| 117.8 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,716.9 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.5 | 2.6 |
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper... gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida. Read more
Non-Independent Director & CEO
Mr. Mark Pomeranz
Non-Independent Director & CEO
Mr. Mark Pomeranz
Headquarters
Fort Lauderdale, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Motus GI Holdings Inc (MOTS) is $0.00 (NASDAQ) as of 02-Apr-2026 09:30 EDT. Motus GI Holdings Inc (MOTS) has given a return of -98.1% in the last 3 years.
Since, TTM earnings of Motus GI Holdings Inc (MOTS) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
-0.06
|
0.30
|
|
2022
|
-0.01
|
0.09
|
|
2021
|
0.00
|
0.01
|
|
2020
|
-0.01
|
0.01
|
|
2019
|
-0.01
|
0.01
|
The 52-week high and low of Motus GI Holdings Inc (MOTS) are Rs 0.00 and Rs 0.00 as of 05-Apr-2026.
Motus GI Holdings Inc (MOTS) has a market capitalisation of $ 0 Mln as on 27-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Motus GI Holdings Inc (MOTS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.09
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.